Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Myeloma cell intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy, and ANXA1 inhibition may effectively diminish BCMA-negative myeloma.”
Authors: Shuangshuang Yang, Guixiang Wang, Jiahuan Chen, Wu Zhang, Jing Wu, Weiqing, Liu, Ling Bai, Peide Huang, Jianqing Mi, Jie Xu.
More posts featuring Robert Orlowski.
